J
Janux Therapeutics D
D
JANX
50.600
USD
4.07
(8.75%)
مغلق
حجم التداول
29,242
الربح لكل سهم
-1
العائد الربحي
-
P/E
-43
حجم السوق
2,655,590,212
العنوان: Janux Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.